SurgeonMelanoma Institute Australia, The University of Sydney, Sydney, NSW, Australia, United States
59: Surgical considerations for resecting the index lymph node after neo-adjuvant checkpoint inhibitors: lessons learned from the PRADO trial
Friday, March 22, 20242:02pm – 2:14pm ET